omeprazole has been researched along with sulfamerazine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| El-Eswed, BI; Qaisi, AM; Tutunji, LF; Tutunji, MF | 1 |
| Forte, JG; Guan, S; Machen, TE; Watson, C; Zhu, L | 1 |
4 other study(ies) available for omeprazole and sulfamerazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole.
Topics: Anti-Ulcer Agents; Buffers; Dimerization; Disulfides; Drug Stability; Electrodes; Enzyme Inhibitors; Hydrogen-Ion Concentration; Mercaptoethanol; Mercury; Models, Chemical; Omeprazole; Polarography; Proton Pump Inhibitors; Sulfamerazine; Sulfenic Acids; Sulfhydryl Compounds; Time Factors | 2007 |
Reaction of proton pump inhibitors with model peptides results in novel products.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Catalytic Domain; Cysteine; Enzyme Inhibitors; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Lansoprazole; Mass Spectrometry; Molecular Structure; Omeprazole; Pantoprazole; Peptides; Proton Pump Inhibitors; Pyridones; Sulfamerazine | 2013 |